Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

INTRODUCTION: Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre‐direct‐acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, and increased risk of allograft rejecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immun Inflamm Dis
Main Authors: Alkadi, Mohamad M., Abuhelaiqa, Essa A., Elshirbeny, Mostafa F., Hamdi, Ahmed F., Fituri, Omar M., Asim, Muhammad, Alkaabi, Saad R., Derbala, Moutaz F., Jarman, Mona E., Ashour, Adel M., Nauman, Awais, Al Maslamani, Yousuf K., Butt, Adeel A., Al‐Malki, Hassan A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7860605/
https://ncbi.nlm.nih.gov/pubmed/33264509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.386
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados